| Preferred Name |
glipalamide |
| Synonyms |
SPC 703 |
| ID |
http://purl.bioontology.org/ontology/MESH/C009971 |
| altLabel |
SPC 703 SPC-703 4,5-dihydro-5-methyl-N-((4-methylphenyl)sulfonyl)-1H-pyrazole-1-carboxamide N-(p-toluenesulfonyl)-5-methyl-delta(2)-pyrazoline-1-carbamide glipalamide, 14C-labeled glipolamid |
| cui |
C0243356 C0074951 C0889012 |
| HM |
D013453 |
| Inverse of RB |
W7J490CUHM 60032-33-9 |
| Mapped to | |
| MDA |
19750101 |
| MeSH Frequency |
9 |
| MMR |
20150926 |
| notation |
C009971 |
| PI |
PYRAZOLES (75-82) |
| prefLabel |
glipalamide |
| RR |
60032-33-9 (14C-labeled cpd) 37598-94-0 (glipalamide) |
| SC |
1 |
| Scope Statement |
an antidiabetic drug; RN given refers to parent cpd |
| SRC |
Pol J Pharmacol Pharm 27(1):45;1975 Endocrinol Pol 27(1):37;1976 Pol Tyg Lek 33(40):1583;1978 Pol Tyg Lek 32(39):1501;1977 Pol J Pharmacol Pharm 28(2):129;1976 Pol J Pharmacol Pharm 29(5):469;1977 |
| TERMUI |
T085127 T085125 T085126 T085124 T340984 T085128 |
| TH |
NLM (1975) FDA SRS (2015) USAN (1994) INN (19XX) |
| tui |
T109 T121 T130 |
| Delete | Mapping To | Ontology | Source |
|---|---|---|---|
| http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C72797 | National Cancer Institute Thesaurus | LOOM |